Trade Mark Journal No.2026/034 21 August 2026
WO0000001444039 (9,10,44)
Office of origin: United States of America
Date of International Registration:26 October 2018
Date of designation in the UK:
15 July 2026

- Class 9
- Software and hardware for use in insulin monitoring and tracking blood glucose levels; software and hardware for use in the acquisition, storage, sharing and analysis of medical and physiological data in the field of diabetes management; software and hardware for predicting blood glucose levels and controlling medicament delivery in the field of diabetes management.
- Class 10
- Medical devices, namely, infusion pumps and peripheral devices, namely, infusion sets for diabetes care for supplying medicaments and related therapies to patients.
- Class 44
- Interactive medical monitoring, reporting and alert services for infusion pump users for medical treatment purposes; providing medical information and data from devices to medical professionals and patients via a website for medical monitoring purposes; telemedicine services.
Tandem Diabetes Care, Inc.
Representative: Louis K. Ebling Thompson Hine LLP, 312 Walnut Street, , Suite 1400, Cincinnati OH 45202, UNITED STATES OF AMERICA